ImmunoPrecise Antibodies (IPATF) Stock Price, News & Analysis

Company Overview

ImmunoPrecise Antibodies Ltd. is a biotechnology company that provides antibody discovery and development services to pharmaceutical, biotechnology and research organizations. The company helps clients identify and optimize antibodies for applications including therapeutic development, diagnostics and research.

Its offerings include antibody generation through animal immunization, hybridoma and phage-display technologies, as well as single-cell sequencing, antibody engineering, characterization and production support. ImmunoPrecise also applies computational and artificial-intelligence tools to antibody discovery through its BioStrand subsidiary and related technology platforms, designed to help analyze biological data and identify potential therapeutic candidates.

ImmunoPrecise Antibodies is headquartered in Victoria, British Columbia, Canada, and serves customers internationally through its laboratory and technology operations. The company has also pursued the internal development of antibody-based therapeutics in addition to its contract research and development activities. Jennifer Bath has served as the company’s chief executive officer.

Key Stats

• Today's Range: $1.30 to $1.37
• 50-Day Range: $1.13 to $1.48
• 52-Week Range: $1.15 to $20.25
• Volume: 117,083 shs
• Average Volume: 20,327 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: OTCMKTS:IPATF
• CIK: N/A
• Web: ipatherapeutics.com
• Phone: (250) 483-0308
• Fax: N/A
• Employees: 80
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A